|
HY-112929B-50mg
|
MedChemexpress LLC
|
(1S,2S,3R)-DT-061 [CAS 1809427-20-0]
|
|
Cancer-programmed cell death
|
|
|
HY-112929B-1mL
|
MedChemexpress LLC
|
(1S,2S,3R)-DT-061 [CAS 1809427-20-0] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-126390-1mg
|
MedChemexpress LLC
|
(E/Z)-BCI [CAS 15982-84-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-18956-2mg
|
MedChemexpress LLC
|
(E/Z)-Icerguastat [CAS 13098-73-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-W007599-100g
|
MedChemexpress LLC
|
(S)-2,6-Bis((tert-butoxycarbonyl)amino)hexanoic acid [CAS 2483-46-7]
|
|
Cancer-programmed cell death
|
|
|
HY-W007599-25g
|
MedChemexpress LLC
|
(S)-2,6-Bis((tert-butoxycarbonyl)amino)hexanoic acid [CAS 2483-46-7]
|
|
Cancer-programmed cell death
|
|
|
HY-W007599-50g
|
MedChemexpress LLC
|
(S)-2,6-Bis((tert-butoxycarbonyl)amino)hexanoic acid [CAS 2483-46-7]
|
|
Cancer-programmed cell death
|
|
|
HY-106961A-1mg
|
MedChemexpress LLC
|
(Z)-ONO 1301 [CAS 153814-74-5]
|
|
|
|
|
HY-106961A-5mg
|
MedChemexpress LLC
|
(Z)-ONO 1301 [CAS 153814-74-5]
|
|
|
|
|
HY-N4226-1g
|
MedChemexpress LLC
|
1-Methyl-6-oxo-1,6-dihydropyridine-3-carboxylic acid [CAS 3719-45-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-N4226-500mg
|
MedChemexpress LLC
|
1-Methyl-6-oxo-1,6-dihydropyridine-3-carboxylic acid [CAS 3719-45-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-N4226-1mL
|
MedChemexpress LLC
|
1-Methyl-6-oxo-1,6-dihydropyridine-3-carboxylic acid [CAS 3719-45-7] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-113821-10mg
|
MedChemexpress LLC
|
1-Naphthyl phosphate (potassium salt) [CAS 100929-85-9]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-113821-100mg
|
MedChemexpress LLC
|
1-Naphthyl phosphate (potassium salt) [CAS 100929-85-9]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-113821-5mg
|
MedChemexpress LLC
|
1-Naphthyl phosphate (potassium salt) [CAS 100929-85-9]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-113821-50mg
|
MedChemexpress LLC
|
1-Naphthyl phosphate (potassium salt) [CAS 100929-85-9]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-19776-10mg
|
MedChemexpress LLC
|
3Alpha-Aminocholestane [CAS 2206-20-4]
|
|
Cancer-programmed cell death
|
|
|
HY-19776-100mg
|
MedChemexpress LLC
|
3Alpha-Aminocholestane [CAS 2206-20-4]
|
|
Cancer-programmed cell death
|
|
|
HY-19776-25mg
|
MedChemexpress LLC
|
3Alpha-Aminocholestane [CAS 2206-20-4]
|
|
Cancer-programmed cell death
|
|
|
HY-19776-5mg
|
MedChemexpress LLC
|
3Alpha-Aminocholestane [CAS 2206-20-4]
|
|
Cancer-programmed cell death
|
|
|
HY-19776-50mg
|
MedChemexpress LLC
|
3Alpha-Aminocholestane [CAS 2206-20-4]
|
|
Cancer-programmed cell death
|
|
|
HY-19776-1mL
|
MedChemexpress LLC
|
3Alpha-Aminocholestane [CAS 2206-20-4] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-N6663-100mg
|
MedChemexpress LLC
|
3-Carene [CAS 13466-78-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-N6663-50mg
|
MedChemexpress LLC
|
3-Carene [CAS 13466-78-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-78144-1g
|
MedChemexpress LLC
|
4-Methylsalicylic acid [CAS 50-85-1]
|
|
|
|
